THORACIC CANCER
Clinical trials for THORACIC CANCER explained in plain language.
Never miss a new study
Get alerted when new THORACIC CANCER trials appear
Sign up with your email to follow new studies for THORACIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Hearing shield: new drug may prevent Chemo-Induced hearing loss in adults
Symptom relief Not yet recruitingThis study tests whether a drug called Pedmark (sodium thiosulfate) can reduce hearing loss in adults receiving cisplatin chemotherapy for cancers like testicular, head and neck, or thoracic cancer. About 25 adults will receive Pedmark alongside their standard chemo to see if it …
Matched conditions: THORACIC CANCER
Phase: PHASE1, PHASE2 • Sponsor: University of Arizona • Aim: Symptom relief
Last updated May 11, 2026 20:52 UTC
-
New study explores hidden drug interactions in immunotherapy
Knowledge-focused Not yet recruitingThis study looks at how immunotherapy drugs (immune checkpoint inhibitors) might change the way the liver processes other medications. Researchers will give 80 cancer patients a mix of 7 common drugs to measure these effects. The goal is to understand and reduce side effects from…
Matched conditions: THORACIC CANCER
Phase: EARLY_PHASE1 • Sponsor: Indiana University • Aim: Knowledge-focused
Last updated May 13, 2026 15:59 UTC